In-line, doing fine

Xaar has confirmed that trading is in line with guidance, and reiterated FY25 expectations (to 31 December). This […]

02/10/2025 View Research

‘Growth cures all ills’: Xaar H1 performance

Interim results headline with a return to revenue growth, +7% Y/Y, with Printhead revenue +20% Y/Y. Growth was […]

12/08/2025 View Research

New Chair appointment

Ahead of interim results (12 August), Xaar appoints a new Chair, Ben Stocks. Mr Stocks brings 35 years […]

05/08/2025 View Research

Wish upon a Xaar

Xaar shares, +69.4% YTD, are the top-performing share among our UK tech selection (n=72), -3.6% YTD. Enthusiasm is […]

05/06/2025 View Research

The Xaars are aligned

Xaar delivered an in-line FY24 result (Adj EBITDA £3.7m, vs our £3.6m estimate) with a notable beat to […]

25/03/2025 View Research

A curate’s egg with immediate opportunities in the pipeline

Today’s FY trading update features a beat on net cash (£8.2m vs our £7.4m estimate), profitability ‘in line’, […]

15/01/2025 View Research

Board changes

With the departure of long-standing CFO Ian Tichias to pursue other opportunities, Xaar has appointed Paul James as […]

20/11/2024 View Research

Transition gathers pace

Today’s in-line results headline with strong sales traction from new printhead products (+24%Y/Y) vs the decline in legacy […]

18/09/2024 View Research

H1 trading update: ‘In-line’ reassurance

Xaar has issued a reassuring H1 trading update. While the previously identified ‘challenging market conditions’ continue, pleasingly trading […]

30/07/2024 View Research

Board additions emphasise scale-up expertise

Board changes at Xaar will be welcomed by the investment community. On 30 May, Xaar announced the appointment […]

03/06/2024 View Research